web analytics
15.8 C
Munich
Saturday, July 24, 2021

TAG

CYDY

CytoDyn’s Robust Platform Technology Keeps Expanding Into Breakthrough Therapy Designation Territory

Leronlimab is an immunomodulator that targets many diseases Multiple indications being pursued in parallel Proven safety profile, novel mechanism of action, & ease...

CytoDyn Inc (OTCMKTS: CYDY) Gaining as Vyrologix (leronlimab-PRO 140) Top Line Data Looms

CytoDyn Inc (OTCMKTS: CYDY) is making an explosive move up the charts in recent weeks on a massive wave of buy volume and heavy...

Powerful Rise on CytoDyn Inc (OTCMKTS: CYDY) as Vyrologix™ (leronlimab-PRO 140) Gains Traction

CytoDyn Inc (OTCMKTS: CYDY) is in full beast mode skyrocketing up the charts on record setting volume easily surpassing all 3 moving averages and...

Comeback Time for CytoDyn Inc (OTCMKTS:CYDY) NP Talks BLA for the USA, UK and Canada

CytoDyn Inc (OTCMKTS:CYDY) is making an explosive move up the charts since a brief dip below $1.70 per share. New coronavirus cases have been...

Bulls Take Charge of CytoDyn Inc (OTCMKTS:CYDY) as Leronlimab Gains Traction

CytoDyn Inc (OTCMKTS:CYDY) is moving northbound in recent trading as the Company continues to announce promising results for Leronlimab as a treatment for coronavirus....

Leronlimab; Positive CC Put CytoDyn Inc (OTCMKTS:CYDY) Back on Track

CytoDyn Inc (OTCMKTS:CYDY) is heating up fast on a surge of volume and is heading upwards again after 2 weeks of choppy waters. With...

Latest news